EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 216 filers reported holding EDITAS MEDICINE INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $225,000 | +703.6% | 3,206 | +218.7% | 0.04% | +514.3% |
| Q3 2020 | $28,000 | -6.7% | 1,006 | 0.0% | 0.01% | -12.5% |
| Q2 2020 | $30,000 | +50.0% | 1,006 | +3.7% | 0.01% | +14.3% |
| Q1 2020 | $20,000 | -33.3% | 970 | 0.0% | 0.01% | -12.5% |
| Q4 2019 | $30,000 | +25.0% | 970 | 0.0% | 0.01% | +14.3% |
| Q3 2019 | $24,000 | -40.0% | 970 | -38.5% | 0.01% | -36.4% |
| Q2 2019 | $40,000 | 0.0% | 1,576 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $40,000 | +400.0% | 1,576 | +398.7% | 0.01% | +266.7% |
| Q4 2018 | $8,000 | -33.3% | 316 | 0.0% | 0.00% | -25.0% |
| Q3 2018 | $12,000 | 0.0% | 316 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $12,000 | -99.9% | 316 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $10,444,000 | +105.9% | 316 | +90.4% | 0.00% | +50.0% |
| Q4 2017 | $5,072,000 | – | 166 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |